MA26266A1 - Preparations topiques de brivudine stabilisees - Google Patents
Preparations topiques de brivudine stabiliseesInfo
- Publication number
- MA26266A1 MA26266A1 MA27219A MA27219A MA26266A1 MA 26266 A1 MA26266 A1 MA 26266A1 MA 27219 A MA27219 A MA 27219A MA 27219 A MA27219 A MA 27219A MA 26266 A1 MA26266 A1 MA 26266A1
- Authority
- MA
- Morocco
- Prior art keywords
- brivudine
- preparations
- stabilized topical
- topical
- stabilized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01100968 | 2001-01-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA26266A1 true MA26266A1 (fr) | 2004-09-01 |
Family
ID=8176229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA27219A MA26266A1 (fr) | 2001-01-17 | 2003-06-30 | Preparations topiques de brivudine stabilisees |
Country Status (28)
Country | Link |
---|---|
US (1) | US20040087602A1 (fr) |
EP (1) | EP1365772A2 (fr) |
JP (1) | JP2004519460A (fr) |
KR (1) | KR20030070109A (fr) |
CN (1) | CN1236777C (fr) |
AR (1) | AR035530A1 (fr) |
AU (1) | AU2002244642B2 (fr) |
BG (1) | BG107988A (fr) |
BR (1) | BR0206478A (fr) |
CA (1) | CA2434743A1 (fr) |
CZ (1) | CZ20031912A3 (fr) |
EE (1) | EE200300322A (fr) |
HR (1) | HRP20030559A2 (fr) |
HU (1) | HUP0302741A3 (fr) |
IL (1) | IL156933A0 (fr) |
MA (1) | MA26266A1 (fr) |
MX (1) | MXPA03006307A (fr) |
MY (1) | MY136633A (fr) |
NO (1) | NO20033206D0 (fr) |
PE (1) | PE20020818A1 (fr) |
PL (1) | PL365741A1 (fr) |
RU (1) | RU2280453C2 (fr) |
SK (1) | SK8992003A3 (fr) |
TN (1) | TNSN03036A1 (fr) |
UA (1) | UA80673C2 (fr) |
WO (1) | WO2002056913A2 (fr) |
YU (1) | YU57103A (fr) |
ZA (1) | ZA200305437B (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005046769A1 (de) * | 2005-09-29 | 2007-04-05 | Berlin-Chemie Ag | Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus) |
FR2936706B1 (fr) * | 2008-10-08 | 2010-12-17 | Oreal | Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane |
JP5591128B2 (ja) * | 2009-01-29 | 2014-09-17 | 大日本住友製薬株式会社 | 内核を有する口腔内崩壊錠 |
KR102401145B1 (ko) * | 2015-03-19 | 2022-05-23 | 다이이찌 산쿄 가부시키가이샤 | 착색제를 함유하는 고형 제제 |
CN104988791A (zh) * | 2015-06-25 | 2015-10-21 | 广东义晟实业有限公司 | 一种抗病毒添加剂及添加该添加剂的胶水和uv漆 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0072137A1 (fr) * | 1981-08-01 | 1983-02-16 | Beecham Group Plc | Déoxyuridines à activité antivirale |
HU196038B (en) * | 1987-08-07 | 1988-09-28 | Mta Koezponti Kemiai Kutato In | Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine |
DE4122337A1 (de) * | 1991-07-05 | 1993-01-14 | Cedona Pharm Bv | Pharmazeutische zubereitung |
FR2737118B1 (fr) * | 1995-07-28 | 1997-09-05 | Oreal | Composition dermatologique ou pharmaceutique, procede de preparation et utilisation |
GB9521454D0 (en) * | 1995-10-19 | 1995-12-20 | Kappa Pharmaceuticals Ltd | Compositions for the treatment of conditions caused by herpes virus |
US6558710B1 (en) * | 1999-06-14 | 2003-05-06 | Helen Rebecca Godfrey | Topical zinc compositions and methods of use |
DE10162593A1 (de) * | 2001-12-19 | 2003-07-03 | Menarini Ricerche Spa | Stabilisierte topische Brivudin-Formulierungen |
-
2001
- 2001-12-24 MY MYPI20015863A patent/MY136633A/en unknown
-
2002
- 2002-01-10 WO PCT/EP2002/000163 patent/WO2002056913A2/fr not_active Application Discontinuation
- 2002-01-10 IL IL15693302A patent/IL156933A0/xx unknown
- 2002-01-10 KR KR10-2003-7009444A patent/KR20030070109A/ko not_active Application Discontinuation
- 2002-01-10 CN CNB028037448A patent/CN1236777C/zh not_active Expired - Fee Related
- 2002-01-10 EE EEP200300322A patent/EE200300322A/xx unknown
- 2002-01-10 MX MXPA03006307A patent/MXPA03006307A/es not_active Application Discontinuation
- 2002-01-10 EP EP02712810A patent/EP1365772A2/fr not_active Withdrawn
- 2002-01-10 AU AU2002244642A patent/AU2002244642B2/en not_active Ceased
- 2002-01-10 HU HU0302741A patent/HUP0302741A3/hu unknown
- 2002-01-10 CZ CZ20031912A patent/CZ20031912A3/cs unknown
- 2002-01-10 BR BR0206478-2A patent/BR0206478A/pt not_active IP Right Cessation
- 2002-01-10 YU YU57103A patent/YU57103A/sh unknown
- 2002-01-10 US US10/466,305 patent/US20040087602A1/en not_active Abandoned
- 2002-01-10 JP JP2002557420A patent/JP2004519460A/ja active Pending
- 2002-01-10 CA CA002434743A patent/CA2434743A1/fr not_active Abandoned
- 2002-01-10 PL PL02365741A patent/PL365741A1/xx not_active Application Discontinuation
- 2002-01-10 SK SK899-2003A patent/SK8992003A3/sk not_active Application Discontinuation
- 2002-01-10 RU RU2003121639/15A patent/RU2280453C2/ru not_active IP Right Cessation
- 2002-01-16 AR ARP020100151A patent/AR035530A1/es not_active Application Discontinuation
- 2002-01-16 PE PE2002000027A patent/PE20020818A1/es not_active Application Discontinuation
- 2002-10-01 UA UA2003076388A patent/UA80673C2/uk unknown
-
2003
- 2003-06-30 MA MA27219A patent/MA26266A1/fr unknown
- 2003-07-08 TN TNPCT/EP2002/000163A patent/TNSN03036A1/fr unknown
- 2003-07-10 HR HR20030559A patent/HRP20030559A2/hr not_active Application Discontinuation
- 2003-07-10 BG BG107988A patent/BG107988A/bg unknown
- 2003-07-15 ZA ZA200305437A patent/ZA200305437B/xx unknown
- 2003-07-15 NO NO20033206A patent/NO20033206D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1236777C (zh) | 2006-01-18 |
CZ20031912A3 (cs) | 2004-01-14 |
UA80673C2 (en) | 2007-10-25 |
EP1365772A2 (fr) | 2003-12-03 |
WO2002056913A2 (fr) | 2002-07-25 |
EE200300322A (et) | 2003-10-15 |
NO20033206L (no) | 2003-07-15 |
PL365741A1 (en) | 2005-01-10 |
TNSN03036A1 (en) | 2005-04-08 |
HUP0302741A3 (en) | 2007-06-28 |
AR035530A1 (es) | 2004-06-02 |
MXPA03006307A (es) | 2003-09-16 |
CA2434743A1 (fr) | 2002-07-25 |
IL156933A0 (en) | 2004-02-08 |
RU2003121639A (ru) | 2005-02-10 |
RU2280453C2 (ru) | 2006-07-27 |
AU2002244642B2 (en) | 2005-12-15 |
HUP0302741A2 (hu) | 2003-11-28 |
ZA200305437B (en) | 2004-07-15 |
JP2004519460A (ja) | 2004-07-02 |
SK8992003A3 (en) | 2003-11-04 |
MY136633A (en) | 2008-11-28 |
CN1486185A (zh) | 2004-03-31 |
NO20033206D0 (no) | 2003-07-15 |
US20040087602A1 (en) | 2004-05-06 |
KR20030070109A (ko) | 2003-08-27 |
WO2002056913A3 (fr) | 2002-11-07 |
HRP20030559A2 (en) | 2005-06-30 |
BR0206478A (pt) | 2003-12-30 |
BG107988A (bg) | 2004-09-30 |
PE20020818A1 (es) | 2002-10-21 |
YU57103A (sh) | 2006-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1314437T3 (da) | Stabiliserede antistofindeholdende præparater | |
NO20033556D0 (no) | Farmasöytiske preparater | |
IS6040A (is) | Valdekoxib efnablöndur | |
DK1421841T3 (da) | Mejetærsker | |
NO20003967L (no) | Farmasöytiske preparater | |
DE59913150D1 (de) | Spektrometer | |
DE10084057D2 (de) | Miniaturisiertes Spektrometer | |
DE60106275T8 (de) | Dermatologische zusammensetzung | |
DE50106743D1 (de) | Abgassystem | |
DK0988861T3 (da) | Stabiliserede proteinpræparater | |
ATE552577T1 (de) | Duales mautsystem | |
DE60218346D1 (de) | Stabilisierte topische brivudin-formulierungen | |
DE60231590D1 (de) | Haarfärbeverfahren | |
DE60335019D1 (de) | Topische hautpräparate | |
DE60220505D1 (de) | Haarwaschmittel | |
ITMI20011532A0 (it) | Cosmetico solido | |
ATE246494T1 (de) | Brausezubereitungen | |
DE60232960D1 (de) | Mundharmonikakamm | |
MA26266A1 (fr) | Preparations topiques de brivudine stabilisees | |
DE60214042D1 (de) | Nass-trocken-reinigungssystem | |
DE50211902D1 (de) | Systemteil | |
DK199900492A (da) | Spektrometer | |
ITRM20010334A1 (it) | Marmitta di scarico | |
FR2792409B1 (fr) | Spectrometre | |
ATE256754T1 (de) | Gerbstoff-/nachgerbstoffpräparationen |